Project portfolio
IDIBELL has a wide portfolio of innovative projects in different stages of maturity. Here you will find some of our projects that are in “active marketing” status for which we are looking for collaborations with the industry and possible licensees. IDIBELL's innovation portfolio contains more than 150 translational projects in the different IDIBELL Research Areas. We are also open to new collaborations promoted by the industry.
Hero Beats: therapy in your pocket
Authors:
Susana Jiménez-Murcia
Heptammune: first-in-class biologic immunomodulator against Inflammatory Bowel Disease
Authors:
Josep Maria Aran Perramon
Early detection of vomit behaviour in patients with eating disorders
Authors:
Fernando Fernández Aranda
NRF2 activators for the prevention and/or treatment of axonal degeneration
Authors:
Aurora Pujol
Gain-EC: Endometrial cancer
Authors:
Laura Costas
CONAN: Controlled-replication ONcolytic AdeNovirus
Authors:
Rafael Moreno, Ramon Alemany
Modelling disease and cell behaviour using organoids
Authors:
Jordi Guiu
Designing KRAS inhibitors that overcome resistance
Authors:
Albert Antolín
Diagnostic algorithm for the detection of coronary artery disease mediated by blood RNA biomarkers.
Authors:
Marta Tajes, Josep Comín
NeurAntigen: Autoimmune encephalitis diagnose
Authors:
Antonella Consiglio and Eugenia Martínez (H.Clínic)
First-in-class TREX2 inhibitors to treat psoriasis and atopic dermatitis
Authors:
Concepció Soler Prat
X-ALD discordant phenotypes biomarkers
Authors:
Aurora Pujol